Final-Program-ATS-2023-AP.vp

184

MONDAY • MAY 22

P1078 Physiologic Phenotyping of Those at Risk for Recurrent Chronic Obstructive Pulmonary Disease (COPD) Exacerbation/ M. Simon, Providence, RI P1079 Effects of Bronchoscopic Lung Volume Reduction on Oxygen Pulse and Pulse Pressure During Cardiopulmonary Exercise Testing/ J. Ayyoub, Philadelphia, PA P1080 Effects of Bronchoscopic Lung Volume Reduction on Ventilatory Efficiency in Patients With Advanced Emphysema and Severe Hyperinflation/ J. Ayyoub, Philadelphia, PA P1081 Effects of Bronchoscopic Lung Volume Reduction on Diaphragm Morphometric Parameters in Patients With Advanced Emphysema and Severe Hyperinflation/ J. Ayyoub, Philadelphia, PA P1082 Pulmonary Function Test: Part of the Puzzle/ D.M. Shah, New York, NY P1083 Changes in Dyspnea Associated With Pulmonary Function Testing Following Bronchoscopic Lung Volume Reduction/ J.S. Kim, Philadelphia, PA P1084 Changes in Dyspnea Associated With Diaphragm Morphometric Parameters Following Bronchoscopic Lung Volume Reduction/ J.S. Kim, Philadelphia, PA P1085 Ultrasonic Personal Spirometer Appears Accurate and Feasible for Remote Monitoring/ A.L. Crawford, Perth, Australia P1086 Prediction of Carbon Monoxide Diffusing Capacity (DLCO) Using Flow-volume Curve Image in Idiopathic Pulmonary Fibrosis (IPF): An Early Fusion Deep Learning Approach/ W. Chung, Seoul, Korea, Republic of P1087 Bronchodilator Response in Children With Primary Ciliary Dyskinesia/ E.L.A. Seidl, Toronto, Canada P1088 Characterizing the Statistical Properties of Cough Recordings/ B. Suki, Boston, MA P1089 Approximating Spatial Deposition in a Full Volume 3D-Printed Model of the Human Lung Under Physiological Breathing Profiles/ C. Fromen, Newark, DE P1090 Respiratory Function 34 Years After Sulfur Mustard Exposure in Survivors and Controls in Sweden/ F.F. Moradi, Gothenburg, Sweden P1091 Predictive Value of Spirometry Z-Scores for the Development of Pulmonary Complications After Hematopoietic Stem Cell Transplantation/ B.A. White, Rochester, MN

BEHAVIORAL • CLINICAL • TRANSLATIONAL THEMATIC POSTER SESSION

B71

BEYOND CPAP: THERAPIES FOR SLEEP APNEA

9:00 a.m. - 4:15 p.m.

Walter E. Washington Convention Center Area K, Hall C (Lower Level)

Viewing: Posters will be on display for entire session 11:30-1:15 Discussion: 11:30-12:15 authors will be present for individual discussion 12:15-1:15 authors will be present for discussionwith assigned facilitators. P1173 The Effect of Supplemental Oxygen on Hemoglobin Levels in Obstructive Sleep Apnea/ C.D. Turnbull, Oxford, United Kingdom P1174 A Systematic Review and Meta-analysis of the Effects of Nocturnal Oxygen Therapy in Obstructive Sleep Apnea/ S.L. Phyu, Oxford, United Kingdom P1175 Patterns of Adherence to Continuous Positive Airway Pressure (CPAP) and Mandibular Advancement Splints (MAS) in Pregnant Individuals With Sleep-disordered Breathing/ J. Smocot, Montreal, Canada Neuromuscular Electrical Stimulation for Treatment of Obstructive Sleep Apnea/ J.P. Bakker, Needham, MA P1177 An Observational Study Assessing the Safety Profile of Daytime Neuromuscular Electrical Stimulation for Treatment of Obstructive Sleep Apnea/ J.P. Bakker, Needham, MA P1178 Nocturnal Oxygen Therapy for Obstructive Sleep Apnea and Its Effects on Blood Pressure/ S. Ercan, Izmir, Turkey P1179 Transoral Neuromuscular Stimulation for OSA in Veterans/ B. Nokes, La Jolla, CA P1180 A Randomised Controlled Trial Examining the Combined Impact of Acetazolamide and Dronabinol for the Treatment of Obstructive Sleep Apnoea/ L.D.J. Thomson, Melbourne, Australia P1181 Assessing Precision Oral Appliance Efficacy Using Frequency-Based and Risk-Based Indices/ E. Mosca, Pleasanton, CA P1176 Objectively-Monitored Adherence to Daytime

ATS 2023 • Washington, DC